BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 27998645)

  • 1. Thrombotic microangiopathy associated with monoclonal gammopathy.
    Ravindran A; Go RS; Fervenza FC; Sethi S
    Kidney Int; 2017 Mar; 91(3):691-698. PubMed ID: 27998645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
    Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
    Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
    Ali A; Schlanger L; Nasr SH; Sethi S; Gorbatkin SM
    Am J Kidney Dis; 2016 Mar; 67(3):479-82. PubMed ID: 26704376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.
    Cassol CA; Williams MPA; Caza TN; Rodriguez S
    Medicine (Baltimore); 2019 Sep; 98(39):e17148. PubMed ID: 31574818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjögren's syndrome complicated with IgM monoclonal gammopathy of undetermined significance.
    Koga T; Yamasaki S; Nakamura H; Kawakami A; Furusu A; Taguchi T; Eguchi K
    Rheumatol Int; 2013 Jan; 33(1):227-30. PubMed ID: 20652270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
    Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
    J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.
    Chabannes M; Rabant M; El Sissy C; Dragon-Durey MA; Vieira Martins P; Meuleman MS; Karras A; Buob D; Bridoux F; Daugas E; Audard V; Caillard S; Olagne J; Kandel C; Ferlicot S; Philipponnet C; Crepin T; Thervet E; Ducloux D; Frémeaux-Bacchi V; Chauvet S
    Am J Kidney Dis; 2023 Sep; 82(3):279-289. PubMed ID: 37061020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy-associated thrombotic microangiopathy.
    Yui JC; Garceau D; Jhaveri KD; Wanchoo R; Bijol V; Glezerman I; Hassoun H; Dispenzieri A; Russell SJ; Leung N
    Am J Hematol; 2019 Oct; 94(10):E250-E253. PubMed ID: 31257598
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy.
    Gómez-Lechón Quirós L; Acosta De La Vega ME; Compán Fernández O; Pastor Navarro S; Montilla Morales C; Moyano Bueno D; Martín Centellas J; Santos-Briz Terrón A; Hidalgo Calleja C
    Rheumatol Int; 2020 Aug; 40(8):1327-1332. PubMed ID: 32533290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
    Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
    Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.
    Yu XJ; Yu F; Song D; Wang SX; Song Y; Liu G; Zhao MH
    ScientificWorldJournal; 2014; 2014():680502. PubMed ID: 25184151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrological aspects of complement-mediated thrombotic microangiopathy].
    Smirnov AV; Karunnaya AV; Dobronravov VA
    Ter Arkh; 2017; 89(6):34-40. PubMed ID: 28745687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
    Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
    Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.
    Tan SYS; Sibley RK; Belani S; Iwasaki S; Yankulin L; Jonelis T; Higgins JPT; Kambham N; Troxell ML
    J Nephrol; 2018 Dec; 31(6):907-918. PubMed ID: 30334170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.